Chemotherapy Side Effects in Pediatric Oncology
10 Questions
1 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

Administration of cis-retinoic acid is a type of immunotherapy for neuroblastoma.

False

Immunotherapy is used to eliminate residual disease after chemotherapy for neuroblastoma.

True

Stage IV neuroblastoma has a low rate of spontaneous regression.

False

Neuroblastoma has a 5-year survival rate of 50% in children.

<p>False</p> Signup and view all the answers

Recurrent disease is rare in children with neuroblastoma.

<p>False</p> Signup and view all the answers

The prognosis is worse in children diagnosed before 1 year of age.

<p>False</p> Signup and view all the answers

There are no known risk factors associated with osteosarcoma development.

<p>False</p> Signup and view all the answers

Retinoblastoma is not linked to an elevated risk of osteosarcoma development.

<p>False</p> Signup and view all the answers

Fibrous dysplasia is not a risk factor for osteosarcoma.

<p>False</p> Signup and view all the answers

Hereditary multiple exostoses is not a risk factor for osteosarcoma.

<p>False</p> Signup and view all the answers

More Like This

Use Quizgecko on...
Browser
Browser